Publication | Closed Access
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy
33
Citations
20
References
2007
Year
The sulodexide nephropathy programme will document whether therapy with sulodexide confers renal protection in Type 2 diabetes and nephropathy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1